Ocular toxicity associated with mirvetuximab soravtansine: navigating clinical relevance and divergent regulatory recommendations
Fields of Study & Subjects
Drug-Induced Ocular Toxicity
Ocular Oncology and Treatments
Retinal Diseases and Treatments
Publication details
- Journal / source
- International Journal of Gynecological Cancer
- Volume
- 36
- Issue
- 2
- Pages
- 104454–104454
- Publication date
- 5 January 2026
- Language
- EN